TABLE OF CONTENT 1 EXECUTIVE SUMMARY 1.1 OVERVIEW 15 1.1.1 MARKET SYNOPSIS 15 2 MARKET INTRODUCTION 2.1 SCOPE OF THE STUDY 16 2.2 RESEARCH OBJECTIVE 16 2.3 LIST OF ASSUMPTIONS 16 3 RESEARCH METHODOLOGY 3.1.1 OVERVIEW 18 3.2 DATA MINING 18 3.3 SECONDARY RESEARCH 19 3.4 PRIMARY RESEARCH 20 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 20 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 21 3.5 FORECASTING TECHNIQUES 21 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22 3.6.1 BOTTOM-UP APPROACH 23 3.6.2 TOP-DOWN APPROACH 24 3.7 DATA TRIANGULATION 24 3.8 VALIDATION 24 4 MARKET DYNAMICS 4.1 OVERVIEW 25 4.2 DRIVERS 26 4.2.1 RISING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN THE PREVALENCE OF PERIPHERAL ARTERY DISEASES 26 4.2.2 PRODUCT LAUNCH AND TECHNOLOGICAL ADVANCEMENT 26 4.2.3 INCREASING CASES OF DIABETES 27 4.2.4 DRIVERS IMPACT ANALYSIS 27 4.3 RESTRAINTS 28 4.3.1 PRODUCT RECALLS 28 4.3.2 RESTRAINTS IMPACT ANALYSIS 28 4.4 OPPORTUNITIES 28 4.4.1 ENTRY OF MARKET PLAYERS INTO EMERGING ECONOMIES 28 5 MARKET FACTOR ANALYSIS 5.1 PORTER’S FIVE FORCES MODEL 29 5.1.1 THREAT OF NEW ENTRANTS 30 5.1.2 BARGAINING POWER OF SUPPLIERS 30 5.1.3 THREAT OF SUBSTITUTES 30 5.1.4 BARGAINING POWER OF BUYERS 30 5.1.5 INTENSITY OF RIVALRY 30 5.2 VALUE CHAIN ANALYSIS 31 5.2.1 R&D AND DESIGNING 32 5.2.2 MANUFACTURING 32 5.2.3 DISTRIBUTION 32 5.2.4 MARKETING & SALES 32 5.2.5 POST-SALES MONITORING 32 6 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE 6.1 OVERVIEW 33 6.2 DEVICES 34 6.2.1 ANGIOPLASTY BALLOON 36 6.2.2 ANGIOPLASTY STENTS (STENTING) 37 6.2.3 CATHETERS 37 6.2.4 PLAQUE MODIFICATION DEVICES (ATHERECTOMY) 38 6.2.5 HEMODYNAMIC FLOW ALTERATION DEVICES 38 6.3 DRUGS 39 6.3.1 LIPID-LOWERING DRUGS 40 6.3.2 BLOOD PRESSURE LOWERING DRUGS 41 6.3.3 GLUCOSE REGULATING DRUGS 41 6.3.4 BLOOD CLOT PREVENTING DRUGS 42 7 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY END USER 7.1 OVERVIEW 43 7.1.1 HOSPITALS AND CLINICS 45 7.1.2 AMBULATORY SURGERY CENTERS 45 8 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY REGION 8.1 OVERVIEW 46 8.2 AMERICAS 47 8.2.1 NORTH AMERICA 50 8.2.2 LATIN AMERICA 57 8.3 EUROPE 59 8.3.1 WESTERN EUROPE 62 8.3.2 EASTERN EUROPE 78 8.4 ASIA-PACIFIC 80 8.4.1 CHINA 83 8.4.2 JAPAN 85 8.4.3 INDIA 87 8.4.4 AUSTRALIA 89 8.4.5 SOUTH KOREA 91 8.4.6 REST OF ASIA-PACIFIC 93 8.5 MIDDLE EAST & AFRICA 95 8.5.1 MIDDLE EAST 99 8.5.2 AFRICA 101 9 COMPETITIVE LANDSCAPE: GLOBAL PERIPHERAL ARTERY DISEASE MARKET 9.1 OVERVIEW 103 9.2 COMPETITIVE ANALYSIS 103 10 COMPANY PROFILES 10.1 KONINKLIJKE PHILIPS NV 104 10.1.1 COMPANY OVERVIEW 104 10.1.2 FINANCIAL OVERVIEW 105 10.1.3 PRODUCTS/SERVICES OFFERED 106 10.1.4 KEY DEVELOPMENTS 106 10.1.5 SWOT ANALYSIS 107 10.1.6 KEY STRATEGIES 107 10.2 B. BRAUN MELSUNGEN AG 108 10.2.1 COMPANY OVERVIEW 108 10.2.2 FINANCIAL OVERVIEW 109 10.2.3 PRODUCTS/SERVICES OFFERED 109 10.2.4 KEY DEVELOPMENTS 110 10.2.5 SWOT ANALYSIS 110 10.2.6 KEY STRATEGIES 110 10.3 COOK 111 10.3.1 COMPANY OVERVIEW 111 10.3.2 FINANCIAL OVERVIEW 111 10.3.3 PRODUCTS/SERVICES OFFERED 111 10.3.4 KEY DEVELOPMENTS 111 10.3.5 SWOT ANALYSIS 112 10.3.6 KEY STRATEGIES 112 10.4 MEDTRONIC 113 10.4.1 COMPANY OVERVIEW 113 10.4.2 FINANCIAL OVERVIEW 114 10.4.3 PRODUCTS/SERVICES OFFERED 115 10.4.4 MEDTRONIC: KEY DEVELOPMENTS 115 10.4.5 SWOT ANALYSIS 116 10.4.6 KEY STRATEGIES 116 10.5 BAYER AG 117 10.5.1 COMPANY OVERVIEW 117 10.5.2 FINANCIAL OVERVIEW 118 10.5.3 PRODUCTS/SERVICES OFFERED 118 10.5.4 KEY DEVELOPMENTS 119 10.5.5 SWOT ANALYSIS 119 10.5.6 KEY STRATEGIES 119 10.6 BOSTON SCIENTIFIC CORPORATION 120 10.6.1 COMPANY OVERVIEW 120 10.6.2 FINANCIAL OVERVIEW 121 10.6.3 PRODUCTS/SERVICES OFFERED 122 10.6.4 KEY DEVELOPMENTS 122 10.6.5 SWOT ANALYSIS 123 10.6.6 KEY STRATEGIES 123 10.7 BECTON, DICKINSON AND COMPANY 124 10.7.1 COMPANY OVERVIEW 124 10.7.2 FINANCIAL OVERVIEW 125 10.7.3 PRODUCTS/SERVICES OFFERED 125 10.7.4 KEY DEVELOPMENTS 126 10.7.5 SWOT ANALYSIS 126 10.7.6 KEY STRATEGIES 126   10.8 TERUMO MEDICAL CORPORATION 127 10.8.1 COMPANY OVERVIEW 127 10.8.2 FINANCIAL OVERVIEW 128 10.8.3 PRODUCTS OFFERED 128 10.8.4 KEY DEVELOPMENTS 129 10.8.5 SWOT ANALYSIS 129 10.8.6 KEY STRATEGIES 129 10.9 BIOTRONIK 130 10.9.1 COMPANY OVERVIEW 130 10.9.2 FINANCIAL OVERVIEW 130 10.9.3 PRODUCTS OFFERED 130 10.9.4 KEY DEVELOPMENTS 131 10.9.5 SWOT ANALYSIS 132 10.9.6 KEY STRATEGIES 132 10.10 CARDINAL HEALTH 133 10.10.1 COMPANY OVERVIEW 133 10.10.2 FINANCIAL OVERVIEW 134 10.10.3 PRODUCTS OFFERED 135 10.10.4 KEY DEVELOPMENTS 135 10.10.5 SWOT ANALYSIS 136 10.10.6 KEY STRATEGIES 136 11 APPENDIX 11.1 REFERENCES 137 11.2 RELATED REPORTS 137

LIST OF TABLES TABLE 1 LIST OF ASSUMPTIONS 16 TABLE 2 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 34 TABLE 3 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 36 TABLE 4 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR ANGIOPLASTY BALLOON, BY REGION, 2016–2025 (USD MILLION) 36 TABLE 5 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR ANGIOPLASTY STENTS (STENTING), BY REGION, 2016–2025 (USD MILLION) 37 TABLE 6 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR CATHETERS, BY REGION, 2016–2025 (USD MILLION) 37 TABLE 7 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR PLAQUE MODIFICATION DEVICES (ATHERECTOMY), BY REGION, 2016–2025 (USD MILLION) 38 TABLE 8 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR HEMODYNAMIC FLOW ALTERATION DEVICES, BY REGION, 2016–2025 (USD MILLION) 38 TABLE 9 GLOBAL PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 40 TABLE 10 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR LIPID-LOWERING DRUGS, BY REGION, 2016–2025 (USD MILLION) 40 TABLE 11 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR BLOOD PRESSURE LOWERING DRUGS, BY REGION, 2016–2025 (USD MILLION) 41 TABLE 12 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR GLUCOSE REGULATING DRUGS, BY REGION, 2016–2025 (USD MILLION) 41 TABLE 13 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR BLOOD CLOT PREVENTING DRUGS, BY REGION, 2016–2025 (USD MILLION) 42 TABLE 14 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 44 TABLE 15 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR HOSPITALS AND CLINICS, BY REGION, 2016–2025 (USD MILLION) 45 TABLE 16 GLOBAL PERIPHERAL ARTERY DISEASE MARKET FOR AMBULATORY SURGERY CENTERS, BY END USER, 2016–2025 (USD MILLION) 45 TABLE 17 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2016–2025 (USD MILLION) 47 TABLE 18 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2016–2025 (USD MILLION) 48 TABLE 19 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 48 TABLE 20 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 49 TABLE 21 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 49 TABLE 22 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 50 TABLE 23 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2016–2025 (USD MILLION) 51 TABLE 24 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 51 TABLE 25 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 52 TABLE 26 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 52 TABLE 27 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 53 TABLE 28 US: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 53 TABLE 29 US: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 54 TABLE 30 US: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 54 TABLE 31 US: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 55 TABLE 32 CANADA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 55 TABLE 33 CANADA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 56 TABLE 34 CANADA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 56 TABLE 35 CANADA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 57 TABLE 36 LATIN AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 57 TABLE 37 LATIN AMERICA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 58 TABLE 38 LATIN AMERICA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 58 TABLE 39 LATIN AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 59 TABLE 40 EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2016–2025 (USD MILLION) 60 TABLE 41 EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 60 TABLE 42 EUROPE: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 61 TABLE 43 EUROPE: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 61 TABLE 44 EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 62 TABLE 45 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 63 TABLE 46 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 64 TABLE 47 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 64 TABLE 48 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 65 TABLE 49 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 65 TABLE 50 GERMANY: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 66 TABLE 51 GERMANY: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 66 TABLE 52 GERMANY: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 67 TABLE 53 GERMANY: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 67 TABLE 54 FRANCE: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 68 TABLE 55 FRANCE: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 68 TABLE 56 FRANCE: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 69 TABLE 57 FRANCE: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 69 TABLE 58 UK: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 70 TABLE 59 UK: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 70 TABLE 60 UK: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 71 TABLE 61 UK: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 71 TABLE 62 ITALY: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 72 TABLE 63 ITALY: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 72 TABLE 64 ITALY: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 73 TABLE 65 ITALY: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 73 TABLE 66 SPAIN: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 74 TABLE 67 SPAIN: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 74 TABLE 68 SPAIN: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 75 TABLE 69 SPAIN: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 75 TABLE 70 REST OF WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 76 TABLE 71 REST OF WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 76 TABLE 72 REST OF WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 77 TABLE 73 REST OF WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 77 TABLE 74 EASTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 78 TABLE 75 EASTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 78 TABLE 76 EASTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 79 TABLE 77 EASTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 79 TABLE 78 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 81 TABLE 79 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 81 TABLE 80 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 82 TABLE 81 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 82 TABLE 82 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 83 TABLE 83 CHINA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 83 TABLE 84 CHINA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 84 TABLE 85 CHINA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 84 TABLE 86 CHINA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 85 TABLE 87 JAPAN: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 85 TABLE 88 JAPAN: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 86 TABLE 89 JAPAN: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 86 TABLE 90 JAPAN: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 87 TABLE 91 INDIA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 87 TABLE 92 INDIA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 88 TABLE 93 INDIA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 88 TABLE 94 INDIA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 89 TABLE 95 AUSTRALIA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 89 TABLE 96 AUSTRALIA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 90 TABLE 97 AUSTRALIA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 90 TABLE 98 AUSTRALIA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 91 TABLE 99 SOUTH KOREA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 91 TABLE 100 SOUTH KOREA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 92 TABLE 101 SOUTH KOREA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 92 TABLE 102 SOUTH KOREA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 93 TABLE 103 REST OF ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 93 TABLE 104 REST OF ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 94 TABLE 105 REST OF ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 94 TABLE 106 REST OF ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 95 TABLE 107 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2016–2025 (USD MILLION) 96 TABLE 108 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 97 TABLE 109 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 97 TABLE 110 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 98 TABLE 111 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 98 TABLE 112 MIDDLE EAST: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 99 TABLE 113 MIDDLE EAST: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 99 TABLE 114 MIDDLE EAST: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 100 TABLE 115 MIDDLE EAST: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 100 TABLE 116 AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 101 TABLE 117 AFRICA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 101 TABLE 118 AFRICA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 102 TABLE 119 AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 102 TABLE 120 KONINKLIJKE PHILIPS NV: PRODUCTS/SERVICES OFFERED 106 TABLE 121 KONINKLIJKE PHILIPS NV: KEY DEVELOPMENTS 106 TABLE 122 B. BRAUN MELSUNGEN AG: PRODUCTS/SERVICES OFFERED 109 TABLE 123 B. BRAUN MELSUNGEN AG: KEY DEVELOPMENTS 110 TABLE 124 COOK: PRODUCTS/SERVICES OFFERED 111 TABLE 125 COOK: KEY DEVELOPMENTS 111 TABLE 126 MEDTRONIC: PRODUCTS/SERVICES OFFERED 115 TABLE 127 KEY DEVELOPMENTS 115 TABLE 128 BAYER AG: PRODUCTS/SERVICES OFFERED 118 TABLE 129 BAYER AG: KEY DEVELOPMENTS 119 TABLE 130 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES OFFERED 122 TABLE 131 BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES OFFERED 125 TABLE 132 BECTON, DICKINSON AND COMPANY: KEY DEVELOPMENTS 126 TABLE 133 TERUMO MEDICAL CORPORATION: PRODUCTS OFFERED 128 TABLE 134 TERUMO MEDICAL CORPORATION: KEY DEVELOPMENTS 129 TABLE 135 BIOTRONIK: PRODUCTS OFFERED 130 TABLE 136 BIOTRONIK: KEY DEVELOPMENTS 131 TABLE 137 CARDINAL HEALTH: PRODUCTS OFFERED 135 TABLE 138 CARDINAL HEALTH: KEY DEVELOPMENTS 135 LIST OF FIGURES FIGURE 1 GLOBAL PERIPHERAL ARTERY DISEASE MARKET STRUCTURE 17 FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 23 FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PERIPHERAL ARTERY DISEASE MARKET 25 FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL PERIPHERAL ARTERY DISEASE MARKET 29 FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL PERIPHERAL ARTERY DISEASE MARKET 31 FIGURE 6 GLOBAL PERIPHERAL ARTERY DISEASE MARKET SHARE, BY TREATMENT TYPE, 2018 (%) 33 FIGURE 7 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2018 AND 2025 (USD MILLION) 34 FIGURE 8 GLOBAL PERIPHERAL ARTERY DISEASE MARKET FOR DEVICES, BY TYPE, 2018 AND 2025 (USD MILLION) 35 FIGURE 9 GLOBAL PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2018 AND 2025 (USD MILLION) 39 FIGURE 10 GLOBAL PERIPHERAL ARTERY DISEASE MARKET SHARE, BY END USER, 2018 (%) 43 FIGURE 11 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2018 AND 2025 (USD MILLION) 44 FIGURE 12 GLOBAL PERIPHERAL ARTERY DISEASE MARKET SHARE, BY REGION, 2018 (%) 46 FIGURE 13 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2018 AND 2025 (USD MILLION) 46 FIGURE 14 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2018 AND 2025 (USD MILLION) 47 FIGURE 15 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2018 AND 2025 (USD MILLION) 48 FIGURE 16 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2018 AND 2025 (USD MILLION) 50 FIGURE 17 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2018 AND 2025 (USD MILLION) 51 FIGURE 18 EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2018 AND 2025 (USD MILLION) 59 FIGURE 19 EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2018 AND 2025 (USD MILLION) 60 FIGURE 20 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2018 AND 2025 (USD MILLION) 62 FIGURE 21 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2018 AND 2025 (USD MILLION) 63 FIGURE 22 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2018 AND 2025 (USD MILLION) 80 FIGURE 23 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2018 AND 2025 (USD MILLION) 80 FIGURE 24 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2018 AND 2025 (USD MILLION) 95 FIGURE 25 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2018 AND 2025 (USD MILLION) 96 FIGURE 26 GLOBAL: MARKET SHARE OF MAJIOUR COMPETITORS, 2018 (%) 103 FIGURE 27 KONINKLIJKE PHILIPS NV: FINANCIAL OVERVIEW SNAPSHOT 105 FIGURE 28 KONINKLIJKE PHILIPS NV: SWOT ANALYSIS 107 FIGURE 29 B. BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW 109 FIGURE 30 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS 110 FIGURE 31 COOK: SWOT ANALYSIS 112 FIGURE 32 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT 114 FIGURE 33 MEDTRONIC: SWOT ANALYSIS 116 FIGURE 34 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT 118 FIGURE 35 BAYER AG: SWOT ANALYSIS 119 FIGURE 36 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 121 FIGURE 37 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS 123 FIGURE 38 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT 125   FIGURE 39 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS 126 FIGURE 40 TERUMO MEDICAL CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 128 FIGURE 41 TERUMO MEDICAL CORPORATION: SWOT ANALYSIS 129 FIGURE 42 BIOTRONIK: SWOT ANALYSIS 132 FIGURE 43 CARDIAC HEALTH: FINANCIAL OVERVIEW SNAPSHOT 134 FIGURE 44 CARDINAL HEALTH: SWOT ANALYSIS 136

Koninklijke Philips NV (Netherlands), B. Braun Melsungen AG (Germany), Cook (US), Medtronic (Ireland), Bayer AG (Germany), Boston Scientific Corporation (US), Becton, Dickinson, and Company (BD) (US), Terumo Medical Corporation (Japan ), Biotronik (Germany), Cardinal Health (US), and others